The earlier review (31) (N=56 patients) observed higher levels of retrospectively assessed acute anxiety disorder symptoms and latest PTSD signs or symptoms between patients who gained enantiomer esketamine, compared with those who been given racemic ketamine or opioids; the racemic ketamine group also confirmed mildly elevated acute stress disorder indications https://jamesg555brg3.wiki-racconti.com/user